Skin health company to develop and market its skin health technology

A skin health specialist, which raised £4.5m when it listed on the London stock market last week, will use the funds to drive forward its probiotic technology for skin health applications.

SkinBioTherapeutics, a University of Manchester spin-out, will focus on developing and commercialising its SkinBiotix technology platform.

The funds raised will enable it to focus on its development portfolio of three programmes – in skin care (sensitive skin), anti-infection and eczema.

Leave a reply

2 + six =